Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol bronchodilation study of FENO and small-airway physiology in asthma
ACTRN12619000287134Phase 4Completed
- Sponsor
- University of Otago
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of salbutamol in asthma, sponsored by University of Otago. Primary endpoint: Change in exhaled nitric oxide. Started Mar 2019; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12619000287134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000287134.